348 related articles for article (PubMed ID: 34368263)
1. Association of Direct Oral Anticoagulants vs. Vitamin K Antagonists With Fractures in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis.
Wu X; Hu L; Liu J; Gu Q
Front Cardiovasc Med; 2021; 8():713187. PubMed ID: 34368263
[No Abstract] [Full Text] [Related]
2. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
3. Non-vitamin K oral anticoagulants and risk of fractures: a systematic review and meta-analysis.
Mongkhon P; Fanning L; Wong KHTW; Man KKC; Wong ICK; Lau WCY
Europace; 2021 Jan; 23(1):39-48. PubMed ID: 33085751
[TBL] [Abstract][Full Text] [Related]
4. An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve.
Cao Y; Zheng Y; Li S; Liu F; Xue Z; Yin K; Luo J
Front Cardiovasc Med; 2022; 9():899906. PubMed ID: 35783817
[TBL] [Abstract][Full Text] [Related]
5. Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis.
Gao X; Huang D; Hu Y; Chen Y; Zhang H; Liu F; Luo J
Front Cardiovasc Med; 2022; 9():833329. PubMed ID: 35615562
[TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulants and the risk of osteoporotic fractures in patients with non-valvular atrial fibrillation.
Kuo LT; Lin SJ; Wu VC; Chang JJ; Chu PH; Lin YS
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211011374. PubMed ID: 33995605
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies.
Liu F; Xu Z; Luo J; Yu P; Ma J; Yuan P; Zhu W
Front Cardiovasc Med; 2021; 8():766377. PubMed ID: 34805320
[No Abstract] [Full Text] [Related]
8. Comparative Risks of Fracture Among Direct Oral Anticoagulants and Warfarin: A Systematic Review and Network Meta-Analysis.
Tsai SHL; Hu CW; Shao SC; Tischler EH; Obisesan OH; Vervoort D; Chen WC; Hu JR; Kuo LT
Front Cardiovasc Med; 2022; 9():896952. PubMed ID: 35677694
[TBL] [Abstract][Full Text] [Related]
9. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study.
Lau WCY; Cheung CL; Man KKC; Chan EW; Sing CW; Lip GYH; Siu CW; Lam JKY; Lee ACH; Wong ICK
Ann Intern Med; 2020 Jul; 173(1):1-9. PubMed ID: 32423351
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis.
Li D; Chang P; Zhang H; Bai F; Wu Q
Eur J Clin Pharmacol; 2023 Apr; 79(4):461-471. PubMed ID: 36795127
[TBL] [Abstract][Full Text] [Related]
11. Number needed to treat based on real-world evidence for non-vitamin K antagonist oral anticoagulants versus vitamin K antagonist oral anticoagulants in stroke prevention in patients with non-valvular atrial fibrillation.
Briere JB; Bowrin K; Millier A; Toumi M; Wojciechowski P; Taieb V
J Med Econ; 2019 Aug; 22(8):760-765. PubMed ID: 30969801
[No Abstract] [Full Text] [Related]
12. Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.
Wu T; Lv C; Wu L; Chen W; Lv M; Jiang S; Zhang J
J Neurol; 2022 Feb; 269(2):664-675. PubMed ID: 33594452
[TBL] [Abstract][Full Text] [Related]
13. Effect of edoxaban compared with other oral anticoagulants for stroke prevention in patients with atrial fibrillation: A meta-analysis.
Zhang B; Cheng W; Kaisaier W; Gu Z; Zhu W; Jiang Q
Heliyon; 2023 Nov; 9(11):e21740. PubMed ID: 38027839
[TBL] [Abstract][Full Text] [Related]
14. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants
Trongtorsak A; Thangjui S; Kewcharoen J; Polpichai N; Yodsuwan R; Kittipibul V; Friedman HJ; Estrada AQ
Acta Cardiol; 2021 Nov; 76(9):933-942. PubMed ID: 33393861
[TBL] [Abstract][Full Text] [Related]
16. The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis.
Yang KT; Sun WC; Tsai TJ; Tsay FW; Chen WC; Cheng JS
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33375495
[No Abstract] [Full Text] [Related]
17. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
[TBL] [Abstract][Full Text] [Related]
18. The association of fracture risk in atrial fibrillation patients and long-term anticoagulant therapy category: a systematic review and meta-analysis.
Chen J; Lyu L; Shen J; Zeng C; Chen C; Wei T
PeerJ; 2021; 9():e10683. PubMed ID: 33552723
[TBL] [Abstract][Full Text] [Related]
19. Bleeding Outcomes After Dental Extraction in Patients Under Direct-Acting Oral Anticoagulants vs. Vitamin K Antagonists: A Systematic Review and Meta-Analysis.
Hua W; Huang Z; Huang Z
Front Pharmacol; 2021; 12():702057. PubMed ID: 34776943
[No Abstract] [Full Text] [Related]
20. Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation Across BMI Categories: A Systematic Review and Meta-Analysis.
Zhou Y; Ma J; Zhu W
Am J Cardiovasc Drugs; 2020 Feb; 20(1):51-60. PubMed ID: 31342343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
